In the January 2025 presentation, Jazz Pharmaceuticals expects zanidatamab to potentially receive approval and be launched as ...
In November 2025, Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology firm specializing in therapies for primary ...
Glaciers are flush with microbial life. But, as climate change speeds glacial melting, scientists rush to establish microbial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results